Log In
Print this Print this

subcutaneous elamipretide (MTP-131) (formerly Bendavia, ocuvia, SS-31)

  Manage Alerts
Collapse Summary General Information
Company Stealth BioTherapeutics Inc.
DescriptionMitochondrial-targeting tetrapeptide that binds and stabilizes cardiolipin to promote electron transfer and prevent apoptosis
Molecular Target
Mechanism of Action 
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPhase II
Standard IndicationHeart failure
Indication DetailsTreat chronic heart failure (CHF) with preserved ejection fraction; Treat chronic heart failure (CHF) with reduced ejection fraction
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today